95
Views
17
CrossRef citations to date
0
Altmetric
Research Article

EEG ALPHA SENSITIZATION IN INDIVIDUALIZED HOMEOPATHIC TREATMENT OF FIBROMYALGIA

, , , , , & show all
Pages 1195-1220 | Published online: 07 Jul 2009

References

  • Antelman, S. M. (1994). Time-dependent sensitization in animals: A possible model of multiple chemical sensitivity in humans. Toxicology & Industrial Health, 10(4–5), 335–342.
  • Antelman, S. M., & Caggiula, A. R. (1996). Oscillation follows drug sensitization: Impli- cations. Critical Reviews in Neurobiology, 10(1), 10 1–117.
  • Antelman, S. M., Caggiula, A. R., Gershon, S., Edwards, D. J., Austin, M. C., Kiss, S., & Kocan, D. (1997). Stressor-induced oscillation. A possible model of the bidirectional symptoms in PTSD. Annals of the New York Academy of Sciences, 821, 296–304.
  • Antelman, S. M., Eichler, A. J., Black, C. A., & Kocan, D. (1980). Interchangeability of stress and amphetamine in sensitization. Science, 207(4428), 329–331.
  • Antelman, S. M., Knopf, S., Kocan, D., Edwards, D. J., Ritchie, J. C., & Nemeroff, C. B. (1988). One stressful event blocks multiple actions of diazepam for up to at least a month. Brain Research, 445(2), 380–385.
  • Antelman, S. M., Kocan, D., Knopf, S., Edwards, D. J., & Caggiula, A. R. (1992). One brief exposure to a psychological stressor induces long-lasting, time-dependent sensiti- zation of both the cataleptic and neurochemical responses to haloperidol. Life Sciences, 51(4), 261–266.
  • Bardo, M. T., Bowling, S. L., Rowlett, J. K., Manderscheid, P., Buxton, S. T., & Dwoskin, L. P. (1995). Environmental enrichment attenuates locomotor sensitization, but not in vitro dopamine release, induced by amphetamine. Pharmacology, Biochemistry & Be- havior, 51(2–3), 397–405.
  • Bastide, M., & Lagache, A. (1997). A communication process: A new paradigm applied to high-dilution effects on the living body. Alternative Therapies in Health & Medicine, 3(4), 35–39.
  • Bath, P. A. (1999). Self-rated health as a risk factor for prescribed drug use and future health and social service use in older people. Journal of Gerontology, Series A, 54(11), M565–M570.
  • Bell, I. R., Baldwin, C. M., Fernandez, M., & Schwartz, G. E. (1999). Neural sensitization model for multiple chemical sensitivity: Overview of theory and empirical evidence. Toxicology & Industrial Health, 15(3–4), 295–304.
  • Bell, I. R., Baldwin, C. M., & Schwartz, G. E. (2001). Sensitization studies in chemically intolerant individuals: Implications for individual difference research. Annals of the New York Academy of Sciences, 933, 38–47.
  • Bell, I. R., Baldwin, C. M., & Schwartz, G. E. (2002). Translating a nonlinear systems theory model for homeopathy into empirical tests. Alternative Therapies in Health & Medicine, 8(3), 58–66.
  • Bell, I. R., Baldwin, C. M., Stoltz, E., Walsh, B. T., & Schwartz, G. E. (2001). EEG beta 1 oscillation and sucrose sensitization in fibromyalgia with chemical intolerance. In- ternational Journal of Neuroscience, 108(1–2), 31–42.
  • Bell, I. R., Baldwin, C. M., & Schwartz, G. E. (1998). Illness from low levels of environ- mental chemicals: Relevance to chronic fatigue syndrome and fibromyalgia. American Journal of Medicine, 105 Supplement(3A), 74S–82S.
  • Bell, I. R., Baldwin, C. M., Stoltz, E., Walsh, B. T., & Schwartz, G. E. R. (2001). Concomi- tant environmental chemical intolerance modifies the neurobehavioral presentation of women with fibromyalgia. Journal of Chronic Fatigue Syndrome, 9(1–2), 3–19.
  • Bell, I. R., Koithan, M., Gorman, M. M., & Baldwin, C. M. (2003). Homeopathic practi- tioner views of changes in patients undergoing constitutional treatment for chronic disease. Journal of Alternative & Complementary Medicine, 9(1), 39–50.
  • Bell, I. R., Lewis, D. A, Brooks, A. J., Lewis, S., & Schwartz, G. E. (2003). Gas discharge visualization evaluation of ultramolecular doses of homeopathic medicines under blinded, controlled conditions. Journal of Alternative & Complementary Medicine, 9</i>(1),25–38. Bell, I. R., Lewis, D. A., Brooks, A. J., Schwartz, G. E., Lewis, S. E., Caspi, O., Cunningham, V., & Baldwin, C. Cm. (2004b. Individual differences in response to randomly-assigned active individualized homeopathic and placebo treatment in fibromyalgia: Implications of a double-blind optional crossover design. Journal of Alternative & Complementary Medicine, <i>10, 269–283.
  • Bell, I. R., Lewis, D. A., Schwartz, G. E., Lewis, S. E., Caspi, O., Scott, A., Brooks, A. J., & Baldwin, C. M. (2004c). Electroencephalographic cordance patterns distinguish ex- ceptional clinical responders with fibromyalgia to individualized homeopathic medi- cines. Journal of Alternative & Complementary Medicine, 10, 285–299.
  • Bell, I. R., Lewis, D. A. Brooks, A. J., Schwartz, G. E., Lewis, S. E., Walsh, B. T., & Baldwin, C. M. (2004a). Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo. Rheumatology, 43, 577–582.
  • Bell, I. R., Schwartz, G. E., Hardin, E. E., Baldwin, C. M., & Kline, J. P. (1998). Differ- ential resting qEEG alpha patterns in women with environmental chemical intolerance, depressives, and normals. Biological Psychiatry, 43(5), 376–388.
  • Bell, I. R., Warg-Damiani, L., Baldwin, C. M., Walsh, M. E., & Schwartz, G. E. (1998). Self-reported chemical sensitivity and wartime chemical exposures in Gulf War veter- ans with and without decreased global health ratings. Military Medicine, 163(11), 725– 732.
  • Bellavite, P., & Signorini, A. (2002). The emerging science of homeopathy complexity, biodynamics, and nanopharmacology (2nd ed.). Berkeley: North Atlantic Books.
  • Bernstein, D., Fink, L., & Handelsman, L. (1994). Initial reliability and validity of a new retrospective measure of child abuse and neglect. American Journal of Psychiatry, 151, 1132–1136.
  • Bjijou, Y., De Deurwaerdere, P., Spampinato, U., Stinus, L., & Cador, M. (2002). D-amphetamine- induced behavioral sensitization: Effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex. Neuroscience, 109(3), 499– 516.
  • Calabrese, E. J., & Baldwin, L. A. (2001). Hormesis: A generalizable and unifying hy- pothesis. Critical Reviews in Toxicology, 31, 353–424.
  • Cook, I. A., Leuchter, A. F., Morgan, M., Witte, E., Stubbeman, W. F., Abrams, M., Rosenberg, S., & Uijtdehaage, S. H. (2002). Early changes in prefrontal activity characterize clini- cal responders to antidepressants. Neuropsychopharmacology, 27(1), 120–131.
  • Crombag, H. S., Badiani, A., Chan, J., Dell’Orco, J., Dineen, S. P., & Robinson, T. E. (2001). The ability of environmental context to facilitate psychomotor sensitization to amphetamine can be dissociated from its effect on acute drug responsiveness and on conditioned responding. Neuropsychopharmacology, 24(6), 680–690.
  • Davidson, J. (1994). Psychiatry and homeopathy. Basis for a dialogue. British Homoeopathic Journal, 83, 78–83.
  • De Schepper, L. (1999). LM potencies: One of the hidden treasures of the sixth edition of the Organon. British Homoeopathic Journal, 88(3), 128–134.
  • Elia, V., & Niccoli, M. (1999). Thermodynamics of extremely diluted aqueous solutions. Annals of the New York Academy of Sciences, 879, 241–248.
  • Ernst, E., & Hahn, E. G. (Eds.). (1998). Homeopathy. A critical appraisal. Oxford: Butterworth- Heinemann.
  • Ernst, E., & Resch, K. L. (1995). The “optional cross-over design” for randomized con- trolled trials. Fundamental Clinical Pharmacology, 9, 508–511.
  • Ferger, B., Kuschinsky, K. (1996). Effects of cocaine on the EEG power spectrum of rats are significantly altered after its repeated administration: Do they reflect sensitization phenomena? Naunyn-Schmeideberg’s Archives of Pharmacology, 353, 545–551.
  • Fernandez, M., Bell, I. R., & Schwartz, G. E. (1999). EEG sensitization during chemical exposure in women with and without chemical sensitivity of unknown etiology. Toxi- cology & Industrial Health, 15(3–4), 305–312.
  • Fisher, P., Greenwood, A., Huskisson, E.C., Turner, P., & Belon, P. (1989). Effect of ho- meopathic treatment on fibrositis (primary fibromyalgia). British Medical Journal, 299, 365–366.
  • Friedberg, F., & Jason, L. A. (2001). Chronic fatigue syndrome and fibromyalgia: Clinical assessment and treatment. Journal of Clinical Psychology, 57(4), 433–455.
  • Granot, M., Buskila, D., Granovsky, Y., Sprecher, E., Neumann, L., & Yarnitsky, D. (2001). Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia. Clinical Neurophysiology, 112(10), 1881–1887.
  • Harada, H., Shiraishi, K., Kato, T., & Soda, T. (1996). Coherence analysis of EEG changes during odour stimulation in humans. Journal of Laryngology & Otology, 110(7), 652– 656.
  • Hoshaw, B. A., & Lewis, M. J. (2001). Behavioral sensitization to ethanol in rats: Evi- dence from the Sprague-Dawley strain. Pharmacology, Biochemistry & Behavior, 68(4), 685–690.
  • Hyland, M. E., & Lewith, G. T. (2002). Oscillatory effects in a homeopathic clinical trial: An explanation using complexity theory, and implications for clinical practice. Home- opathy, 91(3), 145–149.
  • Idler, E., & Benyamini, Y. (1997). Self-rated health and mortality: A review of twenty- seven community studies. Journal of Health and Social Behavior, 38, 21–36.
  • Idler, E. L., & Kasi, S. (1991). Health perceptions and survival: Do global evaluations of health status really predict mortality? Journal of Gerontology, 46(2), S55–S65.
  • Jonas, W. B., Kaptchuk, T. J., & Linde, K. (2003). A critical overview of homeopathy. Annals of Internal Medicine, 138(5), 393–399.
  • Langman, M. J. S. (1997). Homeopathy trials: Reason for good ones but are they war- ranted? Lancet, 350, 825.
  • Leuchter, A. F., Cook, I. A., Witte, E. A., Morgan, M., & Abrams, M. (2002). Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry, 159(1), 122–129.
  • Linde, K., Clausius, N., Ramirez, G., Melchart, D., Eitel, F., Hedges, L. V., & Jonas, W. B. (1997). Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet, 350, 834–843.
  • Linde, K., Jonas, W. B., Melchart, D., Worku, F., Wagner, H., & Eitel, F. (1994). Critical review and meta-analysis of serial agitated dilutions in experimental toxicology. Hu- man Experimental Toxicology, 13, 481–492.
  • Locatelli, M., Bellodi, L., Grassi, B., & Scarone, S. (1996). EEG power modifications in obsessive-compulsive disorder during olfactory stimulation. Biological Psychiatry, 39(5), 326–331.
  • Locatelli, M., Bellodi, L., Perna, G., & Scarone, S. (1993). EEG power modifications in panic disorder during a temporolimbic activation task: Relationships with temporal lobe clinical symptomatology. Journal of Neuropsychiatry & Clinical Neurosciences, 5(4), 409–414.
  • Masago, R., Matsuda, T., Kikuchi, Y., Miyazaki, Y., Iwanaga, K., Harada, H., & Katsuura, T. (2000). Effects of inhalation of essential oils on EEG activity and sensory evalua- tion. Journal of Physiological Anthropology & Applied Human Science, 19(1), 35–42. McNair, D. M., Lorr, M., & Droppleman, L. F. (1981). Manual for the Profile of Mood States Scale (POMS). San Diego, CA: Educational and Industrial Testing Service.
  • Menec, V. H., Chipperfield, J. G., & Perry, R. P. (1999). Self-perceptions of health: A prospective analysis of mortality, control, and health. Journals of Gerontology Series B-Psychological Sciences & Social Sciences, 54(2), 85–93.
  • Merrell, W. C., & Shalts, E. (2002). Homeopathy. Medical Clinics of North America, 86(1), 47–62.
  • Newlin, D. B., & Thomson, J. B. (1991). Chronic tolerance and sensitization to alcohol in sons of alcoholics. Alcoholism: Clinical & Experimental Research, 15(3), 399– 405.
  • Ostrander, M. M., Hartman, J., Badiani, A., Robinson, T. E., & Gnegy, M. E. (1998). The effect of environment on the changes in calmodulin in rat brain produced by repeated amphetamine treatment. Brain Research, 797(2), 339–341.
  • Pioro-Boisset, M., Esdaile, J. M., & Fitzcharles, M. A. (1996). Alternative medicine use in fibromyalgia syndrome. [comment]. Arthritis Care & Research, 9(1), 13–17.
  • Pontieri, F. E., Monnazzi, P., Scontrini, A., Buttarelli, F. R., & Patacchioli, F. R. (2001). Behavioral sensitization to heroin by cannabinoid pretreatment in the rat. European Journal of Pharmacology, 421(3), R1–R3.
  • Rey, L. (2003). Thermoluminescence of ultra-high dilutions of lithium chloride and so- dium chloride. Physics A, 323, 67–74.
  • Rowe, T. (1998). Homeopathic methodology. Repertory, case taking, and case analysis. Berkeley: North Atlantic Books.
  • Ruiz-Vega, G., Perez-Ordaz, L., Leon-Hueramo, O., Cruz-Vazquez, E., & Sanchez-Diaz, N. (2002). Comparative effect of Coffea cruda potencies on rats. Homeopathy: the Journal of the Faculty of Homeopathy, 91(2), 80–84.
  • Schwartz, G. E., Bell, I. R., Dikman, Z. V., Fernandez, M., Kline, J. P., Peterson, J. M., & Wright, K. P. (1994). EEG responses to low-level chemicals in normals and cacosmics. Toxicology & Industrial Health, 10(4–5), 633–643.
  • Slotkoff, A. T., Radulovic, D. A., & Clauw, D. J. (1997). The relationship between fibromyalgia and the multiple chemical sensitivity syndrome. Scandinavian Journal of Rheumatol- ogy, 26(5), 364–367.
  • Sorg, B., Bailie, T., Tschirgi, M., Li, N., & Wu, W. (2001a). Exposure to repeated low- level formaldehyde in rats increases basal corticosterone levels and enhances the cor- ticosterone response to subsequent formaldehyde. Brain Research, 898(2), 314–320.
  • Sorg, B. A., Bailie, T. M., Tschirgi, M. L., Li, N., & Wu, W. R. (2001b). Exposure to repeated low-level formaldehyde in rats increases basal corticosterone levels and en- hances the corticosterone response to subsequent formaldehyde. Brain Research, 898(2), 314–320.
  • Sorg, B. A., & Prasad, B. M. (1997). Potential role of stress and sensitization in the devel- opment and expression of multiple chemical sensitivity. Environmental Health Per- spectives, 105(Suppl 2), 467–471.
  • Sorg, B. A., Tschirgi, M. L., Swindell, S., Chen, L., & Fang, J. (2001). Repeated formal- dehyde effects in an animal model for multiple chemical sensitivity. Annals of the New York Academy of Sciences, 933, 57–67.
  • Sorg, B. A., Willis, J. R., See, R. E., Hopkins, B., & Westberg, H. H. (1998). Repeated low-level formaldehyde exposure produces cross-sensitization to cocaine: Possible rel- evance to chemical sensitivity in humans. Neuropsychopharmacology, 18(5), 385–394.
  • Stahl, D., Ferger, B., & Kuschinsky, K. (1997). Sensitization to d-amphetamine after its repeated administration: Evidence in EEG and behaviour. Naunyn-Schmiedebergs Ar- chives of Pharmacology, 356(3), 335–340.
  • Staud, R., Vierck, C. J., Cannon, R. L., Mauderli, A. P., & Price, D. D. (2001). Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain, 91(1–2), 165–175.
  • Sukul, N. C., Bala, S. K., & Bhattacharyya, B. (1986). Prolonged cataleptogenic effects of potentized homoeopathic drugs. Psychopharmacology, 89, 338–339.
  • Szarek, M. J., Bell, I. R., & Schwartz, G. E. (1997). Validation of a brief screening mea- sure of environmental chemical sensitivity: The chemical odor intolerance index. Jour- nal of Environmental Psychology, 17(4), 345–351.
  • Tabachnick, B. G., & Fidell, L. S. (2001). Using multivariate statistics (4th ed.). Boston: Allyn and Bacon.
  • Ursin, H., & Eriksen, H. R. (2001). Sensitization, subjective health complaints, and sus- tained arousal. Annals of the New York Academy of Sciences, 933, 119–129.
  • Vandenbroucke, J. P. (1997). Homeopathy trials: Going nowhere. Lancet, 350, 824. Vandenbroucke, J. P., & de Craen, A. J. (2001). Alternative medicine: A “mirror image” for scientific reasoning in conventional medicine. Annals of Internal Medicine, 135(7), 507–513.
  • Vanderwolf, C. H., & Zibrowski, E. M. (2001). Pyriform cortex beta-waves: Odor-specific sensitization following repeated olfactory stimulation. Brain Research, 892(2), 301– 308.
  • Vickers, A. J. (1999). Independent replication of pre-clinical research in homeopathy: A systematic review. Forschende Komplementarmedizin, 6(6), 311–320.
  • Vickers, A. J. (2000). Clinical trials of homeopathy and placebo: Analysis of a scientific debate. Journal of Alternative & Complementary Medicine, 6(1), 49–56.
  • Vithoulkas, G. (1980). The science of homeopathy. NY: Grove Weidenfeld.
  • Walker, E. A., Keegan, D., Gardner, G., Sullivan, M., Bernstein, D., & Katon, W. J. (1997). Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosomatic Medicine, 59(6), 572–577.
  • Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., Fam, A. G., Farber, S. J., Flechter, J. J., Franklin, C. M., Garter, R. A., Hanaty, D., Lessard, J., Lichtbroun, A. A., Niasi, A. T., McCain, G. A., Reynolds, W. J., Romano, T. J., Russell, I. J., & Sheon, R. P. (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee. Arthritis Rheumatism, 33, 160–172.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.